Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer

Parsons HA, Rhoades J, Reed SC, Gydush G, Ram P, Exman P, Xiong K, Lo CC, Li T, Fleharty M, et al. Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer. Clin Cancer Res. 2020;26:2556-2564.
NOTES

Parsons, Heather ARhoades, JustinReed, Sarah CGydush, GregoryRam, PriyankaExman, PedroXiong, KanLo, Christopher CLi, TianyuFleharty, MarkKirkner, Gregory JRotem, DenisseCohen, OfirYu, FangyanFitarelli-Kiehl, MarianaLeong, Ka WaiHughes, Melissa ERosenberg, Shoshana MCollins, Laura CMiller, Kathy DBlumenstiel, BrendanTrippa, LorenzoCibulskis, CarrieNeuberg, Donna SDeFelice, MatthewFreeman, Samuel SLennon, Niall JWagle, NikhilHa, GavinStover, Daniel GChoudhury, Atish DGetz, GadWiner, Eric PMeyerson, MatthewLin, Nancy UKrop, IanLove, J ChristopherMakrigiorgos, G MikePartridge, Ann HMayer, Erica LGolub, Todd RAdalsteinsson, Viktor AengP50 CA168504/CA/NCI NIH HHS/R01 CA221874/CA/NCI NIH HHS/Clin Cancer Res. 2020 Jun 1;26(11):2556-2564. doi: 10.1158/1078-0432.CCR-19-3005. Epub 2020 Mar 13.

Last updated on 05/10/2021